What Do I Do Now?: Neurologic Consultations in Cancer Patients II
Wednesday April 25, 2018 3:30 pm to 5:30 pm
Patrick Wen MD, FAAN
Faculty will discuss the medical and neurologic management of patients with brain tumors and provide an update on the recent advances in treatment of brain tumors; the recent advances in diagnosis and management of paraneoplastic neurologic syndromes; and approximately 10 cases neurologists may encounter when consulting on cancer patients.
This program complements C149: What Do I Do Now?: Neurologic Consultations in Cancer Patients I, but covers independent topics.
Participants should be able to diagnose and treat medical and neurologic complications in brain tumors patients, diagnose and manage paraneoplastic neurologic syndromes, and recognize and treat both common and rare neurologic complications in cancer patients.
Medical Knowledge, Patient Care
Program Speakers - Tentative
3:30 PM - 4:10 PM
Medical Management and Update on Treatments of Brain Tumors
Patrick Y. Wen MD, FAAN
4:10 PM - 4:50 PM
Paraneoplastic Syndromes of the Nervous System
Josep O. Dalmau MD, PhD, FAAN
4:50 PM - 5:30 PM
Case Studies in Cancer Patients
Amy A. Pruitt MD, FAAN
Josep O. Dalmau, MD, PhD, FAAN
Dr. Dalmau has received personal compensation in an editorial capacity for Neurology, Neuroimmunology, Neuroinflammation and UpToDate. Dr. Dalmau has received royalty, license fees, or contractual rights payments from Euroimmune. Dr. Dalmau has received research support from Euroimmune.
Amy A. Pruitt, MD, FAAN
Dr. Pruitt has nothing to disclose.
Patrick Y. Wen, MD, FAAN
Dr. Wen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Abbvie, AstraZeneca, Roche, Ziopharm, Vascular Biogenics, Ziopharm, Taiho, Tocagen, Puma. Dr. Wen has received personal compensation in an editorial capacity for Neuro-Oncology, UpToDate, Elsevier.
Ready to register for the 2018 AAN Annual Meeting?